MedPath

达嘉维康生物制药有限公司

Ownership
-
Established
2022-06-15
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

63

NMPA:63

Drug Approvals

壮元补身酒

Approval Number
国药准字Z43020084
Approval Date
May 29, 2024
NMPA

补肾温阳酒

Approval Number
国药准字B20020572
Approval Date
May 29, 2024
NMPA

风湿酒

Approval Number
国药准字Z43020082
Approval Date
May 29, 2024
NMPA

强身追风酒

Approval Number
国药准字B20020569
Approval Date
May 29, 2024
NMPA

Seven Sons Supplement the kidney wine

Product Name
七子补肾酒
Approval Number
国药准字B20020883
Approval Date
May 29, 2024
NMPA

妇科调经片

Approval Number
国药准字Z20093629
Approval Date
Mar 22, 2024
NMPA

玉叶清火胶囊

Approval Number
国药准字Z20080403
Approval Date
Dec 30, 2022
NMPA

Azithromycin Granules

Product Name
阿奇霉素颗粒
Approval Number
国药准字H20064967
Approval Date
Dec 18, 2020
NMPA

Amoxicillin Capsules

Product Name
阿莫西林胶囊
Approval Number
国药准字H43022230
Approval Date
Aug 10, 2020
NMPA

肠康片

Approval Number
国药准字Z43020328
Approval Date
Aug 4, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.